Clinical Trial Update: IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer [NA]

View source ↗

Summary

Clinical trial update examining IMRT timing in combination with an EGFR-TKI for stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• EGFR-TKI (EGFR tyrosine kinase inhibitor)

Snippet

Sponsor: LuBing | Conditions: Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | NA | Status: UNKNOWN